Global Travel Vaccines Market 2022-2026

海外渡航用ワクチンのグローバル市場2022-2026:インフルエンザ、ジフテリア、肝炎、その他

◆タイトル:Global Travel Vaccines Market 2022-2026
◆商品コード:IRTNTR70539-22
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2022年6月6日
◆ページ数:約120
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:北米、ヨーロッパ、アジア太平洋、その他地域
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥332,500見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥399,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥532,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

テクナビオ社は、世界の海外渡航用ワクチン市場規模が2022年から2026年まで年平均8.59%成長し、24.4億ドルに達すると予測しています。本調査レポートは、海外渡航用ワクチンの世界市場を調査対象とし、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、疾患別(インフルエンザ、ジフテリア、肝炎、その他)分析、顧客状況、地域別状況、推進要因・課題・動向、企業状況、企業分析などの項目を掲載しております。本調査レポートでは、Abbott Laboratories、Altimmune Inc.、AstraZeneca Plc、Bharat Biotech Ltd.、CSL Ltd.、Dynavax Technologies Corp.、Emergent BioSolutions Inc.、GlaxoSmithKline Plc、KM Biologics Co. Ltd.などの企業情報が含まれています。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・世界の海外渡航用ワクチン市場規模:疾患別(インフルエンザ、ジフテリア、肝炎、その他)
・顧客状況
・地域別状況
・推進要因・課題・動向
・企業状況
・企業分析

Global Travel Vaccines Market 2022-2026

Technavio has been monitoring the travel vaccines market and it is poised to grow by $ 2.44 billion during 2022-2026, accelerating at a CAGR of 8.59% during the forecast period. Our report on the travel vaccines market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increase in global migration, increase in awareness about vaccine-preventable diseases among travelers, and mandates by countries on vaccinations prior to issuing visas.
The travel vaccines market analysis includes the disease type segment and geographic landscape.

Technavio’s travel vaccines market is segmented as below:

By Disease Type
• Influenza
• Diptheria
• Hepatitis
• Others

By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the changes in the demographic profile of travelers globally as one of the prime reasons driving the travel vaccines market growth during the next few years. Also, increased incidence of travel-related diseases and initiatives by governments and other organizations to ensure travel safety will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on travel vaccines market covers the following areas:
• Travel vaccines market sizing
• Travel vaccines market forecast
• Travel vaccines market industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading travel vaccines market vendors that include Abbott Laboratories, Altimmune Inc., AstraZeneca Plc, Bharat Biotech Ltd., CSL Ltd., Dynavax Technologies Corp., Emergent BioSolutions Inc., GlaxoSmithKline Plc, KM Biologics Co. Ltd., LG Chem Ltd., Merck and Co. Inc., Mitsubishi Chemical Holdings Corp., Pfizer Inc., Sanofi, Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co. Ltd., Sinovac Biotech Ltd., SK Chemicals Co. Ltd., Takeda Pharmaceutical Co. Ltd., and Valneva SE. Also, the travel vaccines market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/travel-vaccines-market-industry-analysis

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

【資料の目次】

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Disease Type
o Exhibit 06: Executive Summary – Chart on Incremental Growth
o Exhibit 07: Executive Summary – Data Table on Incremental Growth
o Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global – Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global – Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis – Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition – Five forces 2021 and 2026
• 5 Market Segmentation by Disease Type
o 5.1 Market segments
o Exhibit 24: Chart on Disease Type – Market share 2021-2026 (%)
o Exhibit 25: Data Table on Disease Type – Market share 2021-2026 (%)
o 5.2 Comparison by Disease Type
o Exhibit 26: Chart on Comparison by Disease Type
o Exhibit 27: Data Table on Comparison by Disease Type
o 5.3 Influenza – Market size and forecast 2021-2026
o Exhibit 28: Chart on Influenza – Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Influenza – Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Influenza – Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Influenza – Year-over-year growth 2021-2026 (%)
o 5.4 Diptheria – Market size and forecast 2021-2026
o Exhibit 32: Chart on Diptheria – Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Diptheria – Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Diptheria – Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Diptheria – Year-over-year growth 2021-2026 (%)
o 5.5 Hepatitis – Market size and forecast 2021-2026
o Exhibit 36: Chart on Hepatitis – Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Hepatitis – Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Hepatitis – Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Hepatitis – Year-over-year growth 2021-2026 (%)
o 5.6 Others – Market size and forecast 2021-2026
o Exhibit 40: Chart on Others – Market size and forecast 2021-2026 ($ million)
o Exhibit 41: Data Table on Others – Market size and forecast 2021-2026 ($ million)
o Exhibit 42: Chart on Others – Year-over-year growth 2021-2026 (%)
o Exhibit 43: Data Table on Others – Year-over-year growth 2021-2026 (%)
o 5.7 Market opportunity by Disease Type
o Exhibit 44: Market opportunity by Disease Type ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 46: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 48: Chart on Geographic comparison
o Exhibit 49: Data Table on Geographic comparison
o 7.3 North America – Market size and forecast 2021-2026
o Exhibit 50: Chart on North America – Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on North America – Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on North America – Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on North America – Year-over-year growth 2021-2026 (%)
o 7.4 Europe – Market size and forecast 2021-2026
o Exhibit 54: Chart on Europe – Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Europe – Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Europe – Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Europe – Year-over-year growth 2021-2026 (%)
o 7.5 Asia – Market size and forecast 2021-2026
o Exhibit 58: Chart on Asia – Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Asia – Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Asia – Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Asia – Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) – Market size and forecast 2021-2026
o Exhibit 62: Chart on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
o 7.7 US – Market size and forecast 2021-2026
o Exhibit 66: Chart on US – Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on US – Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on US – Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on US – Year-over-year growth 2021-2026 (%)
o 7.8 Germany – Market size and forecast 2021-2026
o Exhibit 70: Chart on Germany – Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on Germany – Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on Germany – Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on Germany – Year-over-year growth 2021-2026 (%)
o 7.9 UK – Market size and forecast 2021-2026
o Exhibit 74: Chart on UK – Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on UK – Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on UK – Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on UK – Year-over-year growth 2021-2026 (%)
o 7.10 Japan – Market size and forecast 2021-2026
o Exhibit 78: Chart on Japan – Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on Japan – Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on Japan – Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on Japan – Year-over-year growth 2021-2026 (%)
o 7.11 China – Market size and forecast 2021-2026
o Exhibit 82: Chart on China – Market size and forecast 2021-2026 ($ million)
o Exhibit 83: Data Table on China – Market size and forecast 2021-2026 ($ million)
o Exhibit 84: Chart on China – Year-over-year growth 2021-2026 (%)
o Exhibit 85: Data Table on China – Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 86: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 87: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 89: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 90: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 91: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 92: Matrix on vendor position and classification
o 10.3 Bharat Biotech Ltd.
o Exhibit 93: Bharat Biotech Ltd. – Overview
o Exhibit 94: Bharat Biotech Ltd. – Product / Service
o Exhibit 95: Bharat Biotech Ltd. – Key news
o Exhibit 96: Bharat Biotech Ltd. – Key offerings
o 10.4 CSL Ltd.
o Exhibit 97: CSL Ltd. – Overview
o Exhibit 98: CSL Ltd. – Business segments
o Exhibit 99: CSL Ltd. – Key news
o Exhibit 100: CSL Ltd. – Key offerings
o Exhibit 101: CSL Ltd. – Segment focus
o 10.5 GlaxoSmithKline Plc
o Exhibit 102: GlaxoSmithKline Plc – Overview
o Exhibit 103: GlaxoSmithKline Plc – Business segments
o Exhibit 104: GlaxoSmithKline Plc – Key news
o Exhibit 105: GlaxoSmithKline Plc – Key offerings
o Exhibit 106: GlaxoSmithKline Plc – Segment focus
o 10.6 Merck and Co. Inc.
o Exhibit 107: Merck and Co. Inc. – Overview
o Exhibit 108: Merck and Co. Inc. – Business segments
o Exhibit 109: Merck and Co. Inc. – Key news
o Exhibit 110: Merck and Co. Inc. – Key offerings
o Exhibit 111: Merck and Co. Inc. – Segment focus
o 10.7 Mitsubishi Chemical Holdings Corp.
o Exhibit 112: Mitsubishi Chemical Holdings Corp. – Overview
o Exhibit 113: Mitsubishi Chemical Holdings Corp. – Business segments
o Exhibit 114: Mitsubishi Chemical Holdings Corp. – Key offerings
o Exhibit 115: Mitsubishi Chemical Holdings Corp. – Segment focus
o 10.8 Pfizer Inc.
o Exhibit 116: Pfizer Inc. – Overview
o Exhibit 117: Pfizer Inc. – Product / Service
o Exhibit 118: Pfizer Inc. – Key news
o Exhibit 119: Pfizer Inc. – Key offerings
o 10.9 Sanofi
o Exhibit 120: Sanofi – Overview
o Exhibit 121: Sanofi – Business segments
o Exhibit 122: Sanofi – Key news
o Exhibit 123: Sanofi – Key offerings
o Exhibit 124: Sanofi – Segment focus
o 10.10 Serum Institute of India Pvt. Ltd.
o Exhibit 125: Serum Institute of India Pvt. Ltd. – Overview
o Exhibit 126: Serum Institute of India Pvt. Ltd. – Product / Service
o Exhibit 127: Serum Institute of India Pvt. Ltd. – Key offerings
o 10.11 SK Chemicals Co. Ltd.
o Exhibit 128: SK Chemicals Co. Ltd. – Overview
o Exhibit 129: SK Chemicals Co. Ltd. – Business segments
o Exhibit 130: SK Chemicals Co. Ltd. – Key offerings
o Exhibit 131: SK Chemicals Co. Ltd. – Segment focus
o 10.12 Takeda Pharmaceutical Co. Ltd.
o Exhibit 132: Takeda Pharmaceutical Co. Ltd. – Overview
o Exhibit 133: Takeda Pharmaceutical Co. Ltd. – Product / Service
o Exhibit 134: Takeda Pharmaceutical Co. Ltd. – Key news
o Exhibit 135: Takeda Pharmaceutical Co. Ltd. – Key offerings
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 136: Inclusions checklist
o Exhibit 137: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 138: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 139: Research methodology
o Exhibit 140: Validation techniques employed for market sizing
o Exhibit 141: Information sources
o 11.5 List of abbreviations
o Exhibit 142: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Disease Type
Exhibits6: Executive Summary – Chart on Incremental Growth
Exhibits7: Executive Summary – Data Table on Incremental Growth
Exhibits8: Executive Summary – Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global – Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global – Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis – Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants – Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes – Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry – Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition – Five forces 2021 and 2026
Exhibits24: Chart on Disease Type – Market share 2021-2026 (%)
Exhibits25: Data Table on Disease Type – Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Disease Type
Exhibits27: Data Table on Comparison by Disease Type
Exhibits28: Chart on Influenza – Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Influenza – Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Influenza – Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Influenza – Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Diptheria – Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Diptheria – Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Diptheria – Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Diptheria – Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Hepatitis – Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Hepatitis – Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Hepatitis – Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Hepatitis – Year-over-year growth 2021-2026 (%)
Exhibits40: Chart on Others – Market size and forecast 2021-2026 ($ million)
Exhibits41: Data Table on Others – Market size and forecast 2021-2026 ($ million)
Exhibits42: Chart on Others – Year-over-year growth 2021-2026 (%)
Exhibits43: Data Table on Others – Year-over-year growth 2021-2026 (%)
Exhibits44: Market opportunity by Disease Type ($ million)
Exhibits45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits46: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits48: Chart on Geographic comparison
Exhibits49: Data Table on Geographic comparison
Exhibits50: Chart on North America – Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on North America – Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on North America – Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on North America – Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Europe – Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Europe – Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Europe – Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Europe – Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Asia – Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Asia – Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Asia – Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Asia – Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on US – Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on US – Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on US – Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on US – Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Germany – Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Germany – Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Germany – Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Germany – Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on UK – Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on UK – Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on UK – Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on UK – Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on Japan – Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on Japan – Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on Japan – Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on Japan – Year-over-year growth 2021-2026 (%)
Exhibits82: Chart on China – Market size and forecast 2021-2026 ($ million)
Exhibits83: Data Table on China – Market size and forecast 2021-2026 ($ million)
Exhibits84: Chart on China – Year-over-year growth 2021-2026 (%)
Exhibits85: Data Table on China – Year-over-year growth 2021-2026 (%)
Exhibits86: Market opportunity By Geographical Landscape ($ million)
Exhibits87: Impact of drivers and challenges in 2021 and 2026
Exhibits88: Overview on Criticality of inputs and Factors of differentiation
Exhibits89: Overview on factors of disruption
Exhibits90: Impact of key risks on business
Exhibits91: Vendors covered
Exhibits92: Matrix on vendor position and classification
Exhibits93: Bharat Biotech Ltd. – Overview
Exhibits94: Bharat Biotech Ltd. – Product / Service
Exhibits95: Bharat Biotech Ltd. – Key news
Exhibits96: Bharat Biotech Ltd. – Key offerings
Exhibits97: CSL Ltd. – Overview
Exhibits98: CSL Ltd. – Business segments
Exhibits99: CSL Ltd. – Key news
Exhibits100: CSL Ltd. – Key offerings
Exhibits101: CSL Ltd. – Segment focus
Exhibits102: GlaxoSmithKline Plc – Overview
Exhibits103: GlaxoSmithKline Plc – Business segments
Exhibits104: GlaxoSmithKline Plc – Key news
Exhibits105: GlaxoSmithKline Plc – Key offerings
Exhibits106: GlaxoSmithKline Plc – Segment focus
Exhibits107: Merck and Co. Inc. – Overview
Exhibits108: Merck and Co. Inc. – Business segments
Exhibits109: Merck and Co. Inc. – Key news
Exhibits110: Merck and Co. Inc. – Key offerings
Exhibits111: Merck and Co. Inc. – Segment focus
Exhibits112: Mitsubishi Chemical Holdings Corp. – Overview
Exhibits113: Mitsubishi Chemical Holdings Corp. – Business segments
Exhibits114: Mitsubishi Chemical Holdings Corp. – Key offerings
Exhibits115: Mitsubishi Chemical Holdings Corp. – Segment focus
Exhibits116: Pfizer Inc. – Overview
Exhibits117: Pfizer Inc. – Product / Service
Exhibits118: Pfizer Inc. – Key news
Exhibits119: Pfizer Inc. – Key offerings
Exhibits120: Sanofi – Overview
Exhibits121: Sanofi – Business segments
Exhibits122: Sanofi – Key news
Exhibits123: Sanofi – Key offerings
Exhibits124: Sanofi – Segment focus
Exhibits125: Serum Institute of India Pvt. Ltd. – Overview
Exhibits126: Serum Institute of India Pvt. Ltd. – Product / Service
Exhibits127: Serum Institute of India Pvt. Ltd. – Key offerings
Exhibits128: SK Chemicals Co. Ltd. – Overview
Exhibits129: SK Chemicals Co. Ltd. – Business segments
Exhibits130: SK Chemicals Co. Ltd. – Key offerings
Exhibits131: SK Chemicals Co. Ltd. – Segment focus
Exhibits132: Takeda Pharmaceutical Co. Ltd. – Overview
Exhibits133: Takeda Pharmaceutical Co. Ltd. – Product / Service
Exhibits134: Takeda Pharmaceutical Co. Ltd. – Key news
Exhibits135: Takeda Pharmaceutical Co. Ltd. – Key offerings
Exhibits136: Inclusions checklist
Exhibits137: Exclusions checklist
Exhibits138: Currency conversion rates for US$
Exhibits139: Research methodology
Exhibits140: Validation techniques employed for market sizing
Exhibits141: Information sources
Exhibits142: List of abbreviations



【掲載企業】

Abbott Laboratories、Altimmune Inc.、AstraZeneca Plc、Bharat Biotech Ltd.、CSL Ltd.、Dynavax Technologies Corp.、Emergent BioSolutions Inc.、GlaxoSmithKline Plc、KM Biologics Co. Ltd.

【免責事項】
※当資料上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当資料に記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当資料上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[海外渡航用ワクチンのグローバル市場2022-2026:インフルエンザ、ジフテリア、肝炎、その他]についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆